Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

Surcinelli A, Kalincik T, Roos I, D'Amico E, Lechner-Scott J, Ozakbas S, Hradilek P, Horáková D, Vachova M, Panzera I, Ruzza S, Piscaglia MG, Gerlach O, Meca-Lallana JE, Valero-López G, Kermode AG, Fabis-Pedrini MJ, Prevost J, Ampapa R, Hodgkinson S, Grand'Maison F, Khoury SJ, John NA, Peterka M, Houskova J, Recmanova E, Rous Z, Shaygannejad V, Alroughani R, Kuhle J, Jakob GB, Grammond P, Patti F, Van der Walt A, Butzkueven H, Foschi M

Open source

DOI: 10.1177/17562864261430084
Published: 2026
Container: Therapeutic advances in neurological disorders
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/17562864261430084,
  title = {Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.},
  author = {Surcinelli A and Kalincik T and Roos I and D'Amico E and Lechner-Scott J and Ozakbas S and Hradilek P and Horáková D and Vachova M and Panzera I and Ruzza S and Piscaglia MG and Gerlach O and Meca-Lallana JE and Valero-López G and Kermode AG and Fabis-Pedrini MJ and Prevost J and Ampapa R and Hodgkinson S and Grand'Maison F and Khoury SJ and John NA and Peterka M and Houskova J and Recmanova E and Rous Z and Shaygannejad V and Alroughani R and Kuhle J and Jakob GB and Grammond P and Patti F and Van der Walt A and Butzkueven H and Foschi M},
  year = {2026},
  journal = {Therapeutic advances in neurological disorders},
  doi = {10.1177/17562864261430084},
  url = {https://doi.org/10.1177/17562864261430084}
}

RIS

TY  - JOUR
TI  - Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.
AU  - Surcinelli A
AU  - Kalincik T
AU  - Roos I
AU  - D'Amico E
AU  - Lechner-Scott J
AU  - Ozakbas S
AU  - Hradilek P
AU  - Horáková D
AU  - Vachova M
AU  - Panzera I
AU  - Ruzza S
AU  - Piscaglia MG
AU  - Gerlach O
AU  - Meca-Lallana JE
AU  - Valero-López G
AU  - Kermode AG
AU  - Fabis-Pedrini MJ
AU  - Prevost J
AU  - Ampapa R
AU  - Hodgkinson S
AU  - Grand'Maison F
AU  - Khoury SJ
AU  - John NA
AU  - Peterka M
AU  - Houskova J
AU  - Recmanova E
AU  - Rous Z
AU  - Shaygannejad V
AU  - Alroughani R
AU  - Kuhle J
AU  - Jakob GB
AU  - Grammond P
AU  - Patti F
AU  - Van der Walt A
AU  - Butzkueven H
AU  - Foschi M
PY  - 2026
JO  - Therapeutic advances in neurological disorders
DO  - 10.1177/17562864261430084
UR  - https://doi.org/10.1177/17562864261430084
ER  -

APA

A, S., T, K., I, R., E, D., J, L., S, O., P, H., D, H., M, V., I, P., S, R., MG, P., O, G., JE, M., G, V., AG, K., MJ, F., J, P., R, A., S, H., F, G., SJ, K., NA, J., M, P., J, H., E, R., Z, R., V, S., R, A., J, K., GB, J., P, G., F, P., A, V. D. W., H, B., & M, F. (2026). Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.. Therapeutic advances in neurological disorders. https://doi.org/10.1177/17562864261430084

Source records

pubmed · retrieved 2026-09-25T10:57:04.576Z